Clinical Trial Update: Clinical, Inflammatory, and Economic Impact of Dextran 70 in Treating Spontaneous Bacterial Peritonitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Dextran 70 for spontaneous bacterial peritonitis was terminated; results assessing clinical, inflammatory, and economic impact…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Bacterial Peritonitis

Drugs mentioned

• Dextran 70 (dextran 70)

Snippet

Sponsor: University of Virginia | Conditions: Spontaneous Bacterial Peritonitis | Phase 4 | Status: TERMINATED | Results posted: 2014-12-03